APO RESEARCH · REPORT
GABA
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Product & engineering
Understand the product.
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Selected research
Industry Growth & Trends
Global GABA Industry Growth and Trends Forecast to 2032
Market perspective
GABA (γ-aminobutyric acid), CAS 56-12-2, is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide range of traditional foods produced by microbial fermentation contain GABA, in which GABA is safe and eco-friendly, and also has the possibility of providing new health-benefited products enriched with GABA. Synthesis of GABA is catalyzed by glutamate decarboxylase, therefore, the optimal fermentation condition is mainly based on the biochemical properties of the enzyme. Major GABA producing microorganisms are lactic acid bacteria (LAB), which make food spoilage pathogens unable to grow and act as probiotics in the gastrointestinal tract.
Global GABA (CAS 56-12-2) key players include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Sino Biotek, Zhejiang Yiwan Bio, etc. Global top five manufacturers hold a share about 45%. China is the largest market, with a share about 90%, followed by Japan, have a share over 3 percent. In terms of Production, Microbial Fermentation (feed grade) is the largest segment, with a share over 77%. And in terms of Application, the largest application is Food, followed by Medicine, Plant Growth Promoter, etc.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global GABA market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The GABA market size, estimates, and forecasts are presented in terms of sales volume (Ton) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GABA market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GABA.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global GABA market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
GABA Market by Company
Pharma Foods International
Kyowa Hakko
Sekisui Chemical
Sino Biotek
Zhejiang Yiwan Bio
Shanghai Richen
Luckerkong
Qandr Biology
Bloomage Biotech
Jyswkj
Zjtr Chemistry
Xinyou Chemistry
Bornsun Biology
Huarui Biology
Viab Life
Microbiofeed
Harworld
GABA Segment by Type
Microbial Fermentation (Feed Grade)
Microbial Fermentation (Food Grade)
Chemical Synthesis
GABA Segment by Application
Animal Feed
Food
Medicine
Plant Growth Promoter
Cosmetic
Other
GABA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GABA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GABA manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of GABA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microbial Fermentation (Feed Grade)
- Microbial Fermentation (Food Grade)
- Chemical Synthesis
Applications
- Animal Feed
- Food
- Medicine
- Plant Growth Promoter
- Cosmetic
- Other
Companies covered
- Pharma Foods International
- Kyowa Hakko
- Sekisui Chemical
- Sino Biotek
- Zhejiang Yiwan Bio
- Shanghai Richen
- Luckerkong
- Qandr Biology
- Bloomage Biotech
- Jyswkj
- Zjtr Chemistry
- Xinyou Chemistry
- Bornsun Biology
- Huarui Biology
- Viab Life
- Microbiofeed
- Harworld
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global GABA Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global GABA Sales Estimates and Forecasts (2021-2032)
- 1.3 GABA Market by Type
- 1.3.1 Microbial Fermentation (Feed Grade)
- 1.3.2 Microbial Fermentation (Food Grade)
- 1.3.3 Chemical Synthesis
- 1.4 Global GABA Market Size by Type
- 1.4.1 Global GABA Market Size Overview by Type (2021-2032)
- 1.4.2 Global GABA Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global GABA Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America GABA Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe GABA Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific GABA Sales Breakdown by Type (2021-2026)
- 1.5.4 South America GABA Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa GABA Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 GABA Industry Trends
- 2.2 GABA Industry Drivers
- 2.3 GABA Industry Opportunities and Challenges
- 2.4 GABA Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by GABA Revenue (2021-2026)
- 3.2 Global Top Players by GABA Sales (2021-2026)
- 3.3 Global Top Players by GABA Price (2021-2026)
- 3.4 Global GABA Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GABA Major Company Production Sites & Headquarters
- 3.6 Global GABA Company, Product Type & Application
- 3.7 Global GABA Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global GABA Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 GABA Players Market Share by Revenue in 2025
- 3.8.3 2025 GABA Tier 1, Tier 2, and Tier 3
4 GABA Regional Status and Outlook
- 4.1 Global GABA Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global GABA Historic Market Size by Region
- 4.2.1 Global GABA Sales in Volume by Region (2021-2026)
- 4.2.2 Global GABA Sales in Value by Region (2021-2026)
- 4.2.3 Global GABA Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global GABA Forecasted Market Size by Region
- 4.3.1 Global GABA Sales in Volume by Region (2027-2032)
- 4.3.2 Global GABA Sales in Value by Region (2027-2032)
- 4.3.3 Global GABA Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GABA by Application
- 5.1 GABA Market by Application
- 5.1.1 Animal Feed
- 5.1.2 Food
- 5.1.3 Medicine
- 5.1.4 Plant Growth Promoter
- 5.1.5 Cosmetic
- 5.1.6 Other
- 5.2 Global GABA Market Size by Application
- 5.2.1 Global GABA Market Size Overview by Application (2021-2032)
- 5.2.2 Global GABA Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global GABA Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America GABA Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe GABA Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific GABA Sales Breakdown by Application (2021-2026)
- 5.3.4 South America GABA Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa GABA Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Pharma Foods International
- 6.1.1 Pharma Foods International Company Information
- 6.1.2 Pharma Foods International Business Overview
- 6.1.3 Pharma Foods International GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Pharma Foods International GABA Product Portfolio
- 6.1.5 Pharma Foods International Recent Developments
- 6.2 Kyowa Hakko
- 6.2.1 Kyowa Hakko Company Information
- 6.2.2 Kyowa Hakko Business Overview
- 6.2.3 Kyowa Hakko GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Kyowa Hakko GABA Product Portfolio
- 6.2.5 Kyowa Hakko Recent Developments
- 6.3 Sekisui Chemical
- 6.3.1 Sekisui Chemical Company Information
- 6.3.2 Sekisui Chemical Business Overview
- 6.3.3 Sekisui Chemical GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sekisui Chemical GABA Product Portfolio
- 6.3.5 Sekisui Chemical Recent Developments
- 6.4 Sino Biotek
- 6.4.1 Sino Biotek Company Information
- 6.4.2 Sino Biotek Business Overview
- 6.4.3 Sino Biotek GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sino Biotek GABA Product Portfolio
- 6.4.5 Sino Biotek Recent Developments
- 6.5 Zhejiang Yiwan Bio
- 6.5.1 Zhejiang Yiwan Bio Company Information
- 6.5.2 Zhejiang Yiwan Bio Business Overview
- 6.5.3 Zhejiang Yiwan Bio GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zhejiang Yiwan Bio GABA Product Portfolio
- 6.5.5 Zhejiang Yiwan Bio Recent Developments
- 6.6 Shanghai Richen
- 6.6.1 Shanghai Richen Company Information
- 6.6.2 Shanghai Richen Business Overview
- 6.6.3 Shanghai Richen GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Richen GABA Product Portfolio
- 6.6.5 Shanghai Richen Recent Developments
- 6.7 Luckerkong
- 6.7.1 Luckerkong Company Information
- 6.7.2 Luckerkong Business Overview
- 6.7.3 Luckerkong GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Luckerkong GABA Product Portfolio
- 6.7.5 Luckerkong Recent Developments
- 6.8 Qandr Biology
- 6.8.1 Qandr Biology Company Information
- 6.8.2 Qandr Biology Business Overview
- 6.8.3 Qandr Biology GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Qandr Biology GABA Product Portfolio
- 6.8.5 Qandr Biology Recent Developments
- 6.9 Bloomage Biotech
- 6.9.1 Bloomage Biotech Company Information
- 6.9.2 Bloomage Biotech Business Overview
- 6.9.3 Bloomage Biotech GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Bloomage Biotech GABA Product Portfolio
- 6.9.5 Bloomage Biotech Recent Developments
- 6.10 Jyswkj
- 6.10.1 Jyswkj Company Information
- 6.10.2 Jyswkj Business Overview
- 6.10.3 Jyswkj GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Jyswkj GABA Product Portfolio
- 6.10.5 Jyswkj Recent Developments
- 6.11 Zjtr Chemistry
- 6.11.1 Zjtr Chemistry Company Information
- 6.11.2 Zjtr Chemistry Business Overview
- 6.11.3 Zjtr Chemistry GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Zjtr Chemistry GABA Product Portfolio
- 6.11.5 Zjtr Chemistry Recent Developments
- 6.12 Xinyou Chemistry
- 6.12.1 Xinyou Chemistry Company Information
- 6.12.2 Xinyou Chemistry Business Overview
- 6.12.3 Xinyou Chemistry GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Xinyou Chemistry GABA Product Portfolio
- 6.12.5 Xinyou Chemistry Recent Developments
- 6.13 Bornsun Biology
- 6.13.1 Bornsun Biology Company Information
- 6.13.2 Bornsun Biology Business Overview
- 6.13.3 Bornsun Biology GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Bornsun Biology GABA Product Portfolio
- 6.13.5 Bornsun Biology Recent Developments
- 6.14 Huarui Biology
- 6.14.1 Huarui Biology Company Information
- 6.14.2 Huarui Biology Business Overview
- 6.14.3 Huarui Biology GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Huarui Biology GABA Product Portfolio
- 6.14.5 Huarui Biology Recent Developments
- 6.15 Viab Life
- 6.15.1 Viab Life Company Information
- 6.15.2 Viab Life Business Overview
- 6.15.3 Viab Life GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Viab Life GABA Product Portfolio
- 6.15.5 Viab Life Recent Developments
- 6.16 Microbiofeed
- 6.16.1 Microbiofeed Company Information
- 6.16.2 Microbiofeed Business Overview
- 6.16.3 Microbiofeed GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Microbiofeed GABA Product Portfolio
- 6.16.5 Microbiofeed Recent Developments
- 6.17 Harworld
- 6.17.1 Harworld Company Information
- 6.17.2 Harworld Business Overview
- 6.17.3 Harworld GABA Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Harworld GABA Product Portfolio
- 6.17.5 Harworld Recent Developments
7 North America by Country
- 7.1 North America GABA Sales by Country
- 7.1.1 North America GABA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America GABA Sales by Country (2021-2026)
- 7.1.3 North America GABA Sales Forecast by Country (2027-2032)
- 7.2 North America GABA Market Size by Country
- 7.2.1 North America GABA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America GABA Market Size by Country (2021-2026)
- 7.2.3 North America GABA Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe GABA Sales by Country
- 8.1.1 Europe GABA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe GABA Sales by Country (2021-2026)
- 8.1.3 Europe GABA Sales Forecast by Country (2027-2032)
- 8.2 Europe GABA Market Size by Country
- 8.2.1 Europe GABA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe GABA Market Size by Country (2021-2026)
- 8.2.3 Europe GABA Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific GABA Sales by Country
- 9.1.1 Asia-Pacific GABA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific GABA Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific GABA Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific GABA Market Size by Country
- 9.2.1 Asia-Pacific GABA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific GABA Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific GABA Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America GABA Sales by Country
- 10.1.1 South America GABA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America GABA Sales by Country (2021-2026)
- 10.1.3 South America GABA Sales Forecast by Country (2027-2032)
- 10.2 South America GABA Market Size by Country
- 10.2.1 South America GABA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America GABA Market Size by Country (2021-2026)
- 10.2.3 South America GABA Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa GABA Sales by Country
- 11.1.1 Middle East and Africa GABA Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa GABA Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa GABA Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa GABA Market Size by Country
- 11.2.1 Middle East and Africa GABA Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa GABA Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa GABA Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 GABA Value Chain Analysis
- 12.1.1 GABA Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 GABA Production Mode & Process
- 12.2 GABA Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 GABA Distributors
- 12.2.3 GABA Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst